You have 3 free guides left 😟
Unlock your guides
You have 3 free guides left 😟
Unlock your guides

, a condition of excessive body fat, wreaks havoc on metabolism. It turns fat tissue into a hormone factory, pumping out substances that mess with and blood pressure. This sets the stage for a host of health problems.

The body fights back, but it's a losing battle. Inflammation takes hold in fat cells, making insulin less effective. This snowballs into a chain reaction, affecting the liver, muscles, and pancreas. It's a perfect storm for metabolic mayhem.

Obesity and Metabolic Disorders

Defining Obesity and Its Metabolic Impact

Top images from around the web for Defining Obesity and Its Metabolic Impact
Top images from around the web for Defining Obesity and Its Metabolic Impact
  • Obesity involves excessive body fat accumulation measured by a Body Mass Index (BMI) of 30 or higher
  • Adipose tissue functions as an endocrine organ in obesity
    • Secretes various and inflammatory mediators
    • Contributes to systemic metabolic dysfunction
  • Obesity strongly associates with
    • Cluster of disorders including , hypertension, and
  • correlates more strongly with metabolic disorders than subcutaneous fat
    • Particularly abdominal fat
  • Chronic low-grade inflammation in adipose tissue links obesity to various metabolic disorders
  • Obesity-induced alterations in adipokine production contribute to metabolic disorders
    • Increased levels
    • Decreased levels

Adipose Tissue Function and Inflammation

  • Adipocyte hypertrophy and hyperplasia occur in obesity
    • Lead to altered adipokine production
    • Increase pro-inflammatory cytokine secretion (, )
  • Chronic activation of inflammatory pathways contributes to insulin resistance
    • NF-κB pathway
    • JNK pathway
  • Adipose tissue inflammation impacts multiple metabolic organs
    • Liver (hepatic insulin resistance)
    • Skeletal muscle (impaired glucose uptake)
    • Pancreas (β-cell dysfunction)
  • Macrophage infiltration in adipose tissue exacerbates inflammation
    • M1 macrophages predominate in obese adipose tissue
    • Release pro-

Insulin Resistance in Type 2 Diabetes

Mechanisms of Insulin Resistance

  • Insulin resistance involves cells becoming less responsive to insulin
    • Leads to impaired glucose uptake and utilization
  • Excess adipose tissue in obesity releases factors interfering with insulin signaling
    • Free fatty acids
    • Inflammatory cytokines (TNF-α, IL-6)
  • Insulin resistance affects multiple organs
    • Liver (increased )
    • Muscle (decreased glucose uptake)
    • Adipose tissue (impaired lipid storage)
  • Molecular mechanisms of insulin resistance include
    • Impaired insulin receptor substrate (IRS) phosphorylation
    • Decreased PI3K/Akt pathway activation
    • Increased activity of protein tyrosine phosphatases (PTP1B)

Progression to Type 2 Diabetes

  • Chronic insulin resistance leads to compensatory
    • Pancreas produces more insulin to maintain normal blood glucose levels
  • occurs over time
    • Pancreas fails to produce sufficient insulin to overcome insulin resistance
    • Results in
  • Progression from insulin resistance to type 2 diabetes involves complex factors
    • (, genes)
    • Environmental factors (diet, physical inactivity)
  • and exacerbate beta-cell dysfunction and insulin resistance
    • Chronic hyperglycemia damages β-cells ()
    • Elevated free fatty acids impair insulin secretion and action

Metabolic Consequences of Obesity

Dyslipidemia in Obesity

  • Obesity-related dyslipidemia characterized by
    • Elevated
    • Decreased
    • Increased small, dense
  • Insulin resistance promotes hepatic triglyceride synthesis and VLDL secretion
    • Contributes to dyslipidemic profile
  • Impaired activity in adipose tissue
    • Reduces triglyceride clearance from circulation
  • Increased hepatic lipase activity
    • Enhances HDL catabolism, lowering HDL levels
  • changes in obesity
    • Increased apoB (found in atherogenic lipoproteins)
    • Decreased apoA-I (major protein in HDL)

Non-Alcoholic Fatty Liver Disease (NAFLD)

  • strongly associates with obesity and insulin resistance
    • Characterized by excessive fat accumulation in the liver
  • Spectrum of NAFLD ranges from to (NASH)
    • Can progress to and
  • Obesity-induced alterations in adipokine production contribute to NAFLD
    • Decreased adiponectin (anti-inflammatory, insulin-sensitizing)
    • Increased leptin (pro-inflammatory)
  • Key metabolic abnormalities in obesity-related NAFLD
    • Increased hepatic
    • Impaired
  • "Two-hit hypothesis" explains NAFLD progression
    • First hit: lipid accumulation sensitizes the liver
    • Second hit: inflammatory insults promote disease progression
  • Insulin resistance in NAFLD
    • Increases lipolysis in adipose tissue, elevating circulating free fatty acids
    • Promotes hepatic lipid accumulation and inflammation

Cellular Stress and Dysfunction

  • Endoplasmic reticulum (ER) stress links obesity to metabolic disorders
    • Activates (UPR)
    • Contributes to insulin resistance and inflammation
  • in obesity
    • Impairs cellular energy metabolism
    • Increases (ROS) production
  • Impaired autophagy in obesity contributes to cellular dysfunction
    • Reduces clearance of damaged organelles and protein aggregates
    • Exacerbates ER stress and inflammation
  • Increased oxidative stress in obesity
    • Results from imbalance between ROS production and antioxidant defenses
    • Damages cellular components (lipids, proteins, DNA)

Systemic and Molecular Mechanisms

  • Obesity-induced alterations in contribute to metabolic dysfunction
    • Changes in ("leaky gut")
    • Altered production of metabolites ()
  • play a role in obesity-related metabolic disorders
    • changes in metabolic genes
    • affecting gene expression
    • Potential for transgenerational transmission of metabolic risk
  • dysregulation in obesity
    • Key regulator of cellular metabolism and growth
    • Contributes to insulin resistance and metabolic dysfunction
  • Adipose tissue expandability hypothesis
    • Limited capacity for healthy adipose tissue expansion
    • Ectopic fat deposition when capacity is exceeded
© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.


© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.

© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.
Glossary
Glossary